chr17-6694158-G-C
Variant summary
Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4_StrongBP6_Very_StrongBP7BS1
The NM_177550.5(SLC13A5):c.1095C>G(p.Thr365Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000713 in 1,613,412 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_177550.5 synonymous
Scores
Clinical Significance
Conservation
Publications
- developmental and epileptic encephalopathy, 25Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)
- undetermined early-onset epileptic encephalopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- amelocerebrohypohidrotic syndromeInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- pyridoxine-dependent epilepsyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -17 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_177550.5. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC13A5 | NM_177550.5 | MANE Select | c.1095C>G | p.Thr365Thr | synonymous | Exon 8 of 12 | NP_808218.1 | ||
| SLC13A5 | NM_001284509.2 | c.1044C>G | p.Thr348Thr | synonymous | Exon 8 of 12 | NP_001271438.1 | |||
| SLC13A5 | NM_001284510.2 | c.966C>G | p.Thr322Thr | synonymous | Exon 7 of 11 | NP_001271439.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| SLC13A5 | ENST00000433363.7 | TSL:1 MANE Select | c.1095C>G | p.Thr365Thr | synonymous | Exon 8 of 12 | ENSP00000406220.2 | ||
| SLC13A5 | ENST00000573648.5 | TSL:1 | c.1095C>G | p.Thr365Thr | synonymous | Exon 8 of 11 | ENSP00000459372.1 | ||
| SLC13A5 | ENST00000293800.10 | TSL:2 | c.1044C>G | p.Thr348Thr | synonymous | Exon 8 of 12 | ENSP00000293800.6 |
Frequencies
GnomAD3 genomes AF: 0.000289 AC: 44AN: 152168Hom.: 0 Cov.: 32 show subpopulations
GnomAD2 exomes AF: 0.0000841 AC: 21AN: 249740 AF XY: 0.0000814 show subpopulations
GnomAD4 exome AF: 0.0000479 AC: 70AN: 1461126Hom.: 0 Cov.: 30 AF XY: 0.0000550 AC XY: 40AN XY: 726830 show subpopulations
Age Distribution
GnomAD4 genome AF: 0.000295 AC: 45AN: 152286Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74474 show subpopulations
Age Distribution
ClinVar
Submissions by phenotype
Inborn genetic diseases Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
Developmental and epileptic encephalopathy, 25 Benign:1
not provided Benign:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at